Jefferies Upgrades Karyopharm To Buy As STORM Data Likely To Predict Sunny Skies

By: via Benzinga
Jefferies has upgraded Karyopharm Therapeutics Inc (NASDAQ: KPTI) to Buy from Hold as it expects the upcoming STORM data to support ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.